FY2025 Earnings Forecast for Flora Growth Corp. Issued By Alliance Global Partners (NASDAQ:FLGC)

Flora Growth Corp. (NASDAQ:FLGC) – Investment analysts at Alliance Global Partners issued their FY2025 earnings estimates for shares of Flora Growth in a report released on Friday, April 5th. Alliance Global Partners analyst A. Grey expects that the company will earn ($0.20) per share for the year. The consensus estimate for Flora Growth’s current full-year earnings is ($0.33) per share.

Separately, Roth Mkm lifted their price objective on Flora Growth to $7.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd.

Flora Growth Trading Down 4.4 %

Flora Growth stock opened at $2.17 on Monday. Flora Growth has a 12 month low of $0.63 and a 12 month high of $5.48. The company has a quick ratio of 0.79, a current ratio of 1.31 and a debt-to-equity ratio of 0.15. The stock has a market cap of $19.49 million, a P/E ratio of -0.22 and a beta of 1.91. The company’s fifty day simple moving average is $1.33 and its 200-day simple moving average is $1.21.

Insider Buying and Selling

In other Flora Growth news, CEO Clifford Starke bought 526,315 shares of Flora Growth stock in a transaction on Monday, April 8th. The stock was purchased at an average cost of $1.90 per share, for a total transaction of $999,998.50. Following the completion of the purchase, the chief executive officer now directly owns 565,714 shares of the company’s stock, valued at $1,074,856.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 17.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Flora Growth

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Flow Traders U.S. LLC bought a new position in shares of Flora Growth in the 1st quarter valued at approximately $26,000. MML Investors Services LLC bought a new position in shares of Flora Growth in the third quarter valued at approximately $34,000. Renaissance Technologies LLC lifted its stake in shares of Flora Growth by 61.1% in the fourth quarter. Renaissance Technologies LLC now owns 452,700 shares of the company’s stock worth $103,000 after buying an additional 171,700 shares during the last quarter. Virtu Financial LLC boosted its holdings in shares of Flora Growth by 88.5% during the 1st quarter. Virtu Financial LLC now owns 63,546 shares of the company’s stock worth $125,000 after buying an additional 29,836 shares during the period. Finally, Citadel Advisors LLC acquired a new position in Flora Growth in the 2nd quarter valued at $212,000. Institutional investors and hedge funds own 36.01% of the company’s stock.

About Flora Growth

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products.